HIGHLIGHTS
- who: Man Xiong and collaborators from the School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China have published the research: MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer, in the Journal: Journal of Oncology of 14/07/2022
- what: The aim of this study was to investigate the role of the HGF/c-MET axis in the proliferation and metastasis in colon cancer. The results of this experiment showed that MACC1 could activate the HGF and then stimulate the phosphorylation of c-MET, thus enhancing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.